Duan Z - Search Results

1

Nanoparticles: a promising modality in the treatment of sarcomas.

Susa M, Milane L, Amiji MM, Hornicek FJ, Duan Z. Susa M, et al. Among authors: duan z. Pharm Res. 2011 Feb;28(2):260-72. doi: 10.1007/s11095-010-0173-z. Epub 2010 May 27. Pharm Res. 2011. PMID: 20505985 Review.

2

Modulation of intracellular ceramide using polymeric nanoparticles to overcome multidrug resistance in cancer.

van Vlerken LE, Duan Z, Seiden MV, Amiji MM. van Vlerken LE, et al. Among authors: duan z. Cancer Res. 2007 May 15;67(10):4843-50. doi: 10.1158/0008-5472.CAN-06-1648. Cancer Res. 2007. PMID: 17510414

3

Paclitaxel and ceramide co-administration in biodegradable polymeric nanoparticulate delivery system to overcome drug resistance in ovarian cancer.

Devalapally H, Duan Z, Seiden MV, Amiji MM. Devalapally H, et al. Among authors: duan z. Int J Cancer. 2007 Oct 15;121(8):1830-8. doi: 10.1002/ijc.22886. Int J Cancer. 2007. PMID: 17557285

4

Modulation of drug resistance in ovarian adenocarcinoma by enhancing intracellular ceramide using tamoxifen-loaded biodegradable polymeric nanoparticles.

Devalapally H, Duan Z, Seiden MV, Amiji MM. Devalapally H, et al. Among authors: duan z. Clin Cancer Res. 2008 May 15;14(10):3193-203. doi: 10.1158/1078-0432.CCR-07-4973. Clin Cancer Res. 2008. PMID: 18483388

5

CDDO-Me, a synthetic triterpenoid, inhibits expression of IL-6 and Stat3 phosphorylation in multi-drug resistant ovarian cancer cells.

Duan Z, Ames RY, Ryan M, Hornicek FJ, Mankin H, Seiden MV. Duan Z, et al. Cancer Chemother Pharmacol. 2009 Mar;63(4):681-9. doi: 10.1007/s00280-008-0785-8. Epub 2008 Jun 28. Cancer Chemother Pharmacol. 2009. PMID: 18587580 Free PMC article.

6

Biodistribution and pharmacokinetic analysis of Paclitaxel and ceramide administered in multifunctional polymer-blend nanoparticles in drug resistant breast cancer model.

van Vlerken LE, Duan Z, Little SR, Seiden MV, Amiji MM. van Vlerken LE, et al. Among authors: duan z. Mol Pharm. 2008 Jul-Aug;5(4):516-26. doi: 10.1021/mp800030k. Epub 2008 Jul 11. Mol Pharm. 2008. PMID: 18616278 Free PMC article.

7

Lentiviral short hairpin RNA screen of genes associated with multidrug resistance identifies PRP-4 as a new regulator of chemoresistance in human ovarian cancer.

Duan Z, Weinstein EJ, Ji D, Ames RY, Choy E, Mankin H, Hornicek FJ. Duan Z, et al. Mol Cancer Ther. 2008 Aug;7(8):2377-85. doi: 10.1158/1535-7163.MCT-08-0316. Epub 2008 Aug 7. Mol Cancer Ther. 2008. PMID: 18687998 Free PMC article.

8

Diverse cross-resistance phenotype to ET-743 and PM00104 in multi-drug resistant cell lines.

Duan Z, Choy E, Jimeno JM, Cuevas Cdel M, Mankin HJ, Hornicek FJ. Duan Z, et al. Cancer Chemother Pharmacol. 2009 May;63(6):1121-9. doi: 10.1007/s00280-008-0843-2. Epub 2008 Oct 1. Cancer Chemother Pharmacol. 2009. PMID: 18828019

9

Multidrug resistant osteosarcoma cell lines exhibit deficiency of GADD45alpha expression.

Yang C, Yang S, Wood KB, Hornicek FJ, Schwab JH, Fondren G, Mankin H, Duan Z. Yang C, et al. Among authors: duan z. Apoptosis. 2009 Jan;14(1):124-33. doi: 10.1007/s10495-008-0282-x. Apoptosis. 2009. PMID: 19052873

10

RAIDD expression is impaired in multidrug resistant osteosarcoma cell lines.

Yang C, Hornicek FJ, Wood KB, Schwab JH, Mankin H, Duan Z. Yang C, et al. Among authors: duan z. Cancer Chemother Pharmacol. 2009 Aug;64(3):607-14. doi: 10.1007/s00280-008-0912-6. Epub 2009 Jan 6. Cancer Chemother Pharmacol. 2009. PMID: 19125251

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

4,062 results

Search Page

Filters